Mariana Chavez-MacGregor
Overview
Explore the profile of Mariana Chavez-MacGregor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
4715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan M, Lei X, Karuturi M, Malinowski C, Giordano S, Chavez-MacGregor M
Breast Cancer Res Treat
. 2025 Feb;
PMID: 40019667
Purpose: Patients with triple-negative breast cancer (TNBC) who have residual disease after neoadjuvant chemotherapy (NACT) benefit from adjuvant capecitabine. Older patients are not always treated according to guidelines, likely due...
2.
Winer E, Levit L, Basch E, Chavez-MacGregor M, Dubois R, Eckhardt S, et al.
J Clin Oncol
. 2025 Feb;
:JCO2402246.
PMID: 39928904
In this statement, ASCO encourages academic medical centers to change their policies and expectations to enhance and promote the professional fulfillment of academic medical oncologists. The statement includes three recommendations...
3.
Kroll J, Jones M, Ann-Yi S, Chavez-MacGregor M, Bruera E, Milbury K
Psychooncology
. 2025 Jan;
34(1):e70069.
PMID: 39788929
Background: Parents with advanced cancer and their partners are more likely to experience psychological distress than their counterparts without minor children. Greater relationship functioning may support parents in distress. Aims:...
4.
Milbury K, Ann-Yi S, Whisenant M, Jones M, Li Y, Necroto V, et al.
Oncologist
. 2024 Dec;
PMID: 39703166
Introduction: Patients with advanced cancer and their spousal caregivers who parent minor children report unmet parenting concerns and increased psychological distress. Seeking to address these important supportive care needs, this...
5.
Zhao H, Shen C, Laureano J, Lei X, Niu J, Giordano S, et al.
Breast Cancer Res Treat
. 2024 Nov;
210(1):191-203.
PMID: 39576449
Purpose: Chemotherapy in combination with trastuzumab is the standard neoadjuvant and adjuvant therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Assessing the regimens administered to patients...
6.
So A, Yi M, Simons J, Kuerer H, Caudle A, DeSnyder S, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):977-978.
PMID: 39562423
No abstract available.
7.
Muppidi N, Adesoye T, Yi M, Sun S, Chavez-MacGregor M, Singh P, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):983-984.
PMID: 39562422
No abstract available.
8.
So A, Yi M, Simons J, Kuerer H, Caudle A, DeSnyder S, et al.
Ann Surg Oncol
. 2024 Oct;
32(2):922-930.
PMID: 39441324
Background: Trials evaluating omission of axillary dissection (ALND) in patients with cN0 breast cancer with positive sentinel lymph nodes (SLNs) have excluded neoadjuvant chemotherapy (NACT). It remains unclear whether the...
9.
Dizman N, Bakouny Z, Haykal T, Riano I, Desai A, Butt A, et al.
JCO Oncol Pract
. 2024 Oct;
21(3):292-299.
PMID: 39374449
Purpose: International medical graduates (IMGs) are an essential component of the oncology workforce in the United States, comprising a third of all practicing oncologists and almost half of hematology/oncology fellows....
10.
Smith G, Smith B, Wu C, Shaitelman S, Chavez-MacGregor M, Murthy R, et al.
Breast
. 2024 Sep;
78:103813.
PMID: 39321504
Background: We evaluated sociodemographic and clinical predictors of financial toxicity (FT) among patients with breast cancer with higher risk clinical factors warranting regional nodal irradiation (RNI). Methods: Among 183 participants...